WEKO3
アイテム
{"_buckets": {"deposit": "6d608207-50e5-4c79-9e58-202c9fd2377a"}, "_deposit": {"created_by": 3, "id": "3681", "owners": [3], "pid": {"revision_id": 0, "type": "depid", "value": "3681"}, "status": "published"}, "_oai": {"id": "oai:rakuno.repo.nii.ac.jp:00003681", "sets": ["34"]}, "author_link": ["9720", "9723", "9722", "9719", "9718", "9721", "9717"], "item_2_biblio_info_9": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2014-11", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "332", "bibliographicPageStart": "329", "bibliographicVolumeNumber": "118", "bibliographic_titles": [{"bibliographic_title": "Life Sciences"}]}]}, "item_2_description_43": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_2_description_6": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "【Aims】 Many studies of human subjects have demonstrated the utility of assessing serum levels of endothelin-1 (ET-1) and big ET-1 as clinical biomarkers in cardiopulmonary and neoplastic diseases. In this study we explored the feasibility of using serum big ET-1 as a reliable veterinary marker in dogs with various cardiopulmonary and neoplastic diseases. 【Main methods】 Serum big ET-1 levels were measured by ELISA in dogs with cardiopulmonary (n = 21) and neoplastic diseases (n = 57). Dogs exhibiting cardiopulmonary disease were divided into two groups based on the velocity of tricuspid valve regurgitation (3.0 \u003e m/s) measured by ultrasound: without and with pulmonary hypertension. Big ET-1 levels for the dogs with the diseases were compared with levels in normal healthy dogs (n = 17). 【Key findings】 Dogs with cardiopulmonary disease (4.6 ± 4.6 pmol/l) showed a significantly (P \u003c 0.01) higher level of big ET-1 than healthy control dogs (1.1 ± 0.53 pmol/l). Serum levels in the dogs with pulmonary hypertension (6.2 ± 5.3 pmol/l) were significantly (P \u003c 0.01) higher than those without pulmonary hypertension (2.0 ± 0.6 pmol/l). Dogs with hemangiosarcoma (5.6 ± 2.2 pmol/l), adenocarcinoma (2.0 ± 1.8 pmol/l), histiocytic sarcoma (3.3 ± 1.9 pmol/l), chondrosarcoma or osteosarcoma (3.0 ± 1.6 pmol/l) and hepatocellular carcinoma (2.7 ± 1.8 pmol/l) showed significantly (P \u003c 0.05) higher levels than healthy control dogs. 【Significance】These findings point to the potential of serum big ET-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs.", "subitem_description_type": "Abstract"}]}, "item_2_publisher_36": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Elsevier Inc."}]}, "item_2_relation_14": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1016/j.lfs.2014.01.002", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_15": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license"}]}, "item_2_rights_16": {"attribute_name": "権利(URI)", "attribute_value_mlt": [{"subitem_rights": "http://creativecommons.org/licenses/by-nc-nd/3.0/ | http://creativecommons.org/licenses/by-nc-nd/3.0/"}]}, "item_2_version_type_19": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Fukumoto, Shinya"}], "nameIdentifiers": [{"nameIdentifier": "9717", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hanazono, Kiwamu"}], "nameIdentifiers": [{"nameIdentifier": "9718", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Miyasho, Taku"}], "nameIdentifiers": [{"nameIdentifier": "9719", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Endo, Yoshifumi"}], "nameIdentifiers": [{"nameIdentifier": "9720", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kadosawa, Tsuyoshi"}], "nameIdentifiers": [{"nameIdentifier": "9721", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Iwano, Hidetomo"}], "nameIdentifiers": [{"nameIdentifier": "9722", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Uchide, Tsuyoshi"}], "nameIdentifiers": [{"nameIdentifier": "9723", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2017-09-19"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "S-2015-210_miyasho.pdf", "filesize": [{"value": "279.8 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 279800.0, "url": {"label": "S-2015-210_miyasho.pdf", "url": "https://rakuno.repo.nii.ac.jp/record/3681/files/S-2015-210_miyasho.pdf"}, "version_id": "f660d5c6-785e-46f4-be9e-49f4d7798f30"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Big endothelin-1", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Dog", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Tumor", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Pulmonary hypertension", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Serum big endothelin-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Serum big endothelin-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs"}]}, "item_type_id": "2", "owner": "3", "path": ["34"], "permalink_uri": "http://hdl.handle.net/10659/4275", "pubdate": {"attribute_name": "公開日", "attribute_value": "2016-05-23"}, "publish_date": "2016-05-23", "publish_status": "0", "recid": "3681", "relation": {}, "relation_version_is_last": true, "title": ["Serum big endothelin-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs"], "weko_shared_id": -1}
Serum big endothelin-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs
http://hdl.handle.net/10659/4275
http://hdl.handle.net/10659/4275a6f12adc-c356-49b4-a24c-d76b13d8691a
名前 / ファイル | ライセンス | アクション |
---|---|---|
S-2015-210_miyasho.pdf (279.8 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2016-05-23 | |||||
タイトル | ||||||
タイトル | Serum big endothelin-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Big endothelin-1 | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Dog | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Tumor | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | Pulmonary hypertension | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Fukumoto, Shinya
× Fukumoto, Shinya× Hanazono, Kiwamu× Miyasho, Taku× Endo, Yoshifumi× Kadosawa, Tsuyoshi× Iwano, Hidetomo× Uchide, Tsuyoshi |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | 【Aims】 Many studies of human subjects have demonstrated the utility of assessing serum levels of endothelin-1 (ET-1) and big ET-1 as clinical biomarkers in cardiopulmonary and neoplastic diseases. In this study we explored the feasibility of using serum big ET-1 as a reliable veterinary marker in dogs with various cardiopulmonary and neoplastic diseases. 【Main methods】 Serum big ET-1 levels were measured by ELISA in dogs with cardiopulmonary (n = 21) and neoplastic diseases (n = 57). Dogs exhibiting cardiopulmonary disease were divided into two groups based on the velocity of tricuspid valve regurgitation (3.0 > m/s) measured by ultrasound: without and with pulmonary hypertension. Big ET-1 levels for the dogs with the diseases were compared with levels in normal healthy dogs (n = 17). 【Key findings】 Dogs with cardiopulmonary disease (4.6 ± 4.6 pmol/l) showed a significantly (P < 0.01) higher level of big ET-1 than healthy control dogs (1.1 ± 0.53 pmol/l). Serum levels in the dogs with pulmonary hypertension (6.2 ± 5.3 pmol/l) were significantly (P < 0.01) higher than those without pulmonary hypertension (2.0 ± 0.6 pmol/l). Dogs with hemangiosarcoma (5.6 ± 2.2 pmol/l), adenocarcinoma (2.0 ± 1.8 pmol/l), histiocytic sarcoma (3.3 ± 1.9 pmol/l), chondrosarcoma or osteosarcoma (3.0 ± 1.6 pmol/l) and hepatocellular carcinoma (2.7 ± 1.8 pmol/l) showed significantly (P < 0.05) higher levels than healthy control dogs. 【Significance】These findings point to the potential of serum big ET-1 as a clinical marker for cardiopulmonary and neoplastic diseases in dogs. | |||||
書誌情報 |
Life Sciences 巻 118, 号 2, p. 329-332, 発行日 2014-11 |
|||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1016/j.lfs.2014.01.002 | |||||
権利 | ||||||
権利情報 | © 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license | |||||
権利(URI) | ||||||
権利情報 | http://creativecommons.org/licenses/by-nc-nd/3.0/ | http://creativecommons.org/licenses/by-nc-nd/3.0/ | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
出版者 | ||||||
出版者 | Elsevier Inc. | |||||
資源タイプ | ||||||
内容記述タイプ | Other | |||||
内容記述 | Article |